Literature DB >> 12612653

Does the ribosome translate cancer?

Davide Ruggero1, Pier Paolo Pandolfi.   

Abstract

Ribosome biogenesis and translation control are essential cellular processes that are governed at numerous levels. Several tumour suppressors and proto-oncogenes have been found either to affect the formation of the mature ribosome or to regulate the activity of proteins known as translation factors. Disruption in one or more of the steps that control protein biosynthesis has been associated with alterations in the cell cycle and regulation of cell growth. Therefore, certain tumour suppressors and proto-oncogenes might regulate malignant progression by altering the protein synthesis machinery. Although many studies have correlated deregulation of protein biosynthesis with cancer, it remains to be established whether this translates directly into an increase in cancer susceptibility, and under what circumstances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612653     DOI: 10.1038/nrc1015

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  398 in total

1.  Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.

Authors:  Cristian Bellodi; Noam Kopmar; Davide Ruggero
Journal:  EMBO J       Date:  2010-05-07       Impact factor: 11.598

2.  RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Authors:  Anthony J Saporita; Hsiang-Chun Chang; Crystal L Winkeler; Anthony J Apicelli; Raleigh D Kladney; Jianbo Wang; R Reid Townsend; Loren S Michel; Jason D Weber
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

3.  Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR.

Authors:  Chi Kwan Tsang; Paula G Bertram; Wandong Ai; Ryan Drenan; X F Steven Zheng
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

4.  Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis.

Authors:  Alice Grob; Pascal Roussel; Jane E Wright; Brian McStay; Danièle Hernandez-Verdun; Valentina Sirri
Journal:  J Cell Sci       Date:  2009-01-27       Impact factor: 5.285

5.  Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.

Authors:  Jian-Wei Zhou; Yuan Li; Li-Xia Yue; Cheng-Lin Luo; Yao Chen; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2015-09-19

Review 6.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

7.  5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs.

Authors:  Feng Fang; Jason Hoskins; J Scott Butler
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Growth inhibitory effects of large subunit ribosomal proteins in melanoma.

Authors:  Gregory R Kardos; Mu-Shui Dai; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-16       Impact factor: 4.693

9.  Codon misreading tRNAs promote tumor growth in mice.

Authors:  Mafalda Santos; Patricia M Pereira; A Sofia Varanda; Joana Carvalho; Mafalda Azevedo; Denisa D Mateus; Nuno Mendes; Patricia Oliveira; Fábio Trindade; Marta Teixeira Pinto; Renata Bordeira-Carriço; Fátima Carneiro; Rui Vitorino; Carla Oliveira; Manuel A S Santos
Journal:  RNA Biol       Date:  2018-06-07       Impact factor: 4.652

10.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.